SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-012862
Filing Date
2019-03-08
Accepted
2019-03-08 09:16:56
Documents
3
Period of Report
2019-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv515762_8k.htm 8-K 37914
2 EXHIBIT 2.1 tv515762_ex2-1.htm EX-2.1 515947
3 EXHIBIT 99.1 tv515762_ex99-1.htm EX-99.1 17344
  Complete submission text file 0001144204-19-012862.txt   572586
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 19667752
SIC: 2834 Pharmaceutical Preparations